The in vivo behavior and antitumor activity of doxorubicin-loaded poly(γ-benzyl l-glutamate)-block-hyaluronan polymersomes in Ehrlich ascites tumor-bearing BalB/c mice.

[1]  A. Bhatt,et al.  In vitro and in vivo evaluation of docetaxel loaded biodegradable polymersomes. , 2010, Macromolecular bioscience.

[2]  Amit Jain,et al.  The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes. , 2010, Biomaterials.

[3]  María J Vicent,et al.  Polymer therapeutics: clinical applications and challenges for development. , 2009, Advanced drug delivery reviews.

[4]  J. Benoit,et al.  Lipid nanocapsules: a new platform for nanomedicine. , 2009, International journal of pharmaceutics.

[5]  A. Misra,et al.  Biomimetic doxorubicin loaded polymersomes from hyaluronan-block-poly(gamma-benzyl glutamate) copolymers. , 2009, Biomacromolecules.

[6]  Kwangmeyung Kim,et al.  Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: synthesis, characterization, and in vivo biodistribution , 2009 .

[7]  Ziming Zhao,et al.  Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers. , 2009, International journal of pharmaceutics.

[8]  Sébastien Lecommandoux,et al.  Polysaccharide-block-polypeptide copolymer vesicles: towards synthetic viral capsids. , 2009, Angewandte Chemie.

[9]  V. Torchilin,et al.  Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy In vivo of Doxorubicin-Loaded, Long-Circulating Liposomes Modified with Cancer-Specific Monoclonal Antibody , 2009, Clinical Cancer Research.

[10]  S. Sen,et al.  Polymersome delivery of siRNA and antisense oligonucleotides. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[11]  H. Maeda,et al.  Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[12]  D. Hammer,et al.  Polymersomes: a new multi-functional tool for cancer diagnosis and therapy. , 2008, Methods.

[13]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[14]  Anil K Patri,et al.  Method for analysis of nanoparticle hemolytic properties in vitro. , 2008, Nano letters.

[15]  S. Steinberg,et al.  Host immunosurveillance controls tumor growth via IFN regulatory factor-8 dependent mechanisms. , 2007, Cancer research.

[16]  Z. Duan,et al.  Paclitaxel and ceramide co‐administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer , 2007, International journal of cancer.

[17]  A. Abbruzzese,et al.  Change in TNF-alpha receptor expression is a relevant event in doxorubicin-induced H9c2 cardiomyocyte cell death. , 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[18]  N. K. Jain,et al.  Investigations on biodistribution of technetium-99m-labeled carbohydrate-coated poly(propylene imine) dendrimers. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[19]  E. Harris,et al.  Expression, Processing, and Glycosaminoglycan Binding Activity of the Recombinant Human 315-kDa Hyaluronic Acid Receptor for Endocytosis (HARE)* , 2007, Journal of Biological Chemistry.

[20]  Ê. Ferreira,et al.  Ehrlich tumor as model to study artificial hyperthyroidism influence on breast cancer. , 2007, Pathology, research and practice.

[21]  K. Kataoka,et al.  Supramolecular assemblies of block copolymers in aqueous media as nanocontainers relevant to biological applications , 2006 .

[22]  T. Minko,et al.  New generation of liposomal drugs for cancer. , 2006, Anti-cancer agents in medicinal chemistry.

[23]  A. Rosato,et al.  Bioavailability of 99mTc-Ha-paclitaxel complex [99mTc-ONCOFID-P] in mice using four different administration routes , 2006 .

[24]  Ruth Duncan,et al.  Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.

[25]  A. Rosato,et al.  HYTAD1-p20: a new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer. , 2006, Urologic oncology.

[26]  Byung Cheol Shin,et al.  In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes. , 2006, International journal of pharmaceutics.

[27]  Frank Bates,et al.  Shrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradation. , 2006, Molecular pharmaceutics.

[28]  M. Dewhirst,et al.  Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. , 2006, Journal of the National Cancer Institute.

[29]  M. Ferrari.  Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[30]  Hua Ai,et al.  Micellar carriers based on block copolymers of poly(ε-caprolactone) and poly(ethylene glycol) for doxorubicin delivery , 2004 .

[31]  D. Coradini,et al.  Inhibition of Hepatocellular Carcinomas in vitro and Hepatic Metastases in vivo in Mice by the Histone Deacetylase Inhibitor HA-But , 2004, Clinical Cancer Research.

[32]  A. Soraci,et al.  A Pharmacokinetic Comparison of Meloxicam and Ketoprofen following Oral Administration to Healthy Dogs , 2004, Veterinary Research Communications.

[33]  D. Peer,et al.  Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor models. , 2004, Neoplasia.

[34]  H. Maeda,et al.  SMA-doxorubicin, a new polymeric micellar drug for effective targeting to solid tumours. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[35]  I. Kwon,et al.  Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone) copolymer as a carrier for paclitaxel , 2003 .

[36]  T. Okano,et al.  Development of the polymer micelle carrier system for doxorubicin. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[37]  H. Hamana,et al.  Characteristics of tissue distribution of various polysaccharides as drug carriers: influences of molecular weight and anionic charge on tumor targeting. , 2001, Biological & pharmaceutical bulletin.

[38]  K. Kataoka,et al.  Block copolymer micelles for drug delivery: design, characterization and biological significance. , 2001, Advanced drug delivery reviews.

[39]  Bin Zhou,et al.  Identification of the Hyaluronan Receptor for Endocytosis (HARE)* , 2000, The Journal of Biological Chemistry.

[40]  T. Nagai,et al.  Pharmacokinetics and Antitumor Effect of Doxorubicin Carried by Stealth and Remote Loading Proliposome , 2000, Pharmaceutical Research.

[41]  H. Ohshima,et al.  Interaction between charged soft microcapsules and red blood cells: effects of PEGylation of microcapsule membranes upon their surface properties , 1999 .

[42]  R. Jain,et al.  Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R K Jain,et al.  Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.

[44]  H. Maeda,et al.  Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. , 1992, Bioconjugate chemistry.

[45]  J. Le Meins,et al.  Role of block copolymer nanoconstructs in cancer therapy. , 2009, Critical reviews in therapeutic drug carrier systems.

[46]  Yaping Li,et al.  The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. , 2009, Biomaterials.

[47]  Y. Fujio,et al.  Beneficial effect of taurine treatment against doxorubicin-induced cardiotoxicity in mice. , 2009, Advances in experimental medicine and biology.

[48]  E. Frenkel,et al.  Nanoparticles for drug delivery in cancer treatment. , 2008, Urologic oncology.

[49]  Kazunori Kataoka,et al.  Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. , 2005, Bioconjugate chemistry.

[50]  M. Marra,et al.  Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours , 2005, Cancer Chemotherapy and Pharmacology.

[51]  Dennis E. Discher,et al.  Polymer vesicles : Materials science: Soft surfaces , 2002 .